Visceral leishmaniasis during pegylated interferon therapy for chronic hepatitis C: first report.

See: Puoti et al. Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antiviral Th...